Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 122
interventional 100
Observational 20
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 46
Device 10
Other 7
Behavioral 5
Dietary Supplement 5
Biological|Drug 4
Drug|Other 3
Drug|placebo 3
Behavioral|Other 2
Drug|Procedure 2
Procedure 2
Behavioral|Other|Procedure 1
Biological 1
Biological|Device|Drug 1
Device|Drug 1
Device|Other 1
Diagnostic Test 1
Diagnostic Test|Other 1
Dietary Supplement|placebo 1
Drug|Radiation 1
Other|Procedure 1
Other|Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 40
China 10
France 5
Cuba 3
Denmark 3
Korea, Republic of 3
NA 3
United Kingdom 3
Germany 2
Netherlands 2
Belgium|France|Spain 1
Brazil|Canada|Cyprus|United Kingdom 1
Canada 1
China|Japan|Korea, Republic of|Taiwan 1
Finland 1
Georgia|Hong Kong|India|Moldova, Republic of|Serbia|Taiwan|Thailand|Ukraine 1
Hong Kong 1
Italy 1
Japan 1
Japan|Korea, Republic of 1
Japan|Spain 1
Korea, Republic of|United States|Canada|Mexico|Russian Federation|Taiwan 1
Norway 1
Russian Federation 1
Spain 1
Sweden 1
Switzerland 1
Taiwan 1
Tunisia 1
United States|Argentina|Brazil|Canada|Chile|China|Estonia|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Peru|Poland|Puerto Rico|Russian Federation|Taiwan|Thailand|Turkey|Ukraine 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|Finland|France|Germany|Hong Kong|Hungary|Ireland|Italy|Korea, Republic of|Netherlands|Portugal|Singapore|Spain|Taiwan|United Kingdom 1
United States|Belgium|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|Canada 1
United States|Germany 1
United States|Japan 1
United States|Mexico 1

Sites per Study

Site_count Study_Count
1 60
2 10
3 6
4 6
5 1
6 1
7 3
8 1
11 1
16 2
17 2
22 1
23 1
27 1
66 1
86 1
183 1
188 1

Phase

Phase Study_Count
N/A 30
Phase 1 24
Phase 2 23
Phase 1/Phase 2 11
Phase 3 6
Phase 4 5
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 46
2 34
3 4
4 2
7 1
NA 13

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 7.00 10.00000 19.0 6.00000 538 30.0000 33
1st Qu. 30.00 19.50000 24.5 32.50000 538 218.2500 42
Median 79.00 24.50000 71.0 50.00000 538 409.0000 60
Mean 283.90 37.79167 128.2 66.47826 538 427.3333 83
3rd Qu. 278.25 40.50000 104.0 66.50000 538 623.7500 120
Max. 3221.00 140.00000 527.0 237.00000 538 866.0000 160

Trial Group Type

group_type Group_Count
Experimental 103
Active Comparator 18
NA 13
No Intervention 8
Other 6
Placebo Comparator 4
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 56
Parallel Assignment 35
Sequential Assignment 4
Crossover Assignment 3
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 71
Supportive Care 13
Diagnostic 7
Other 4
Prevention 3
Basic Science 2

Observational Studies

Studies by Country

Country Study_Count
United States 7
China 2
Spain 2
United Kingdom 2
Denmark 1
France 1
Germany 1
Germany|Serbia|United Kingdom 1
Morocco 1
Norway 1
Thailand 1

Sites per Study

Site_count Study_Count
1 17
3 1
17 1
19 1

Enrollment Metrics

Measure Observational
Min 17.00
1st Qu 115.00
Median 221.00
Mean 1024.80
3rd Qu 589.25
Max 10000.00

Observation Model

observational_model Study_Count
Cohort 12
Case-Only 4
Case-Control 1
Family-Based 1
Other 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 14
Retrospective 4
Cross-Sectional 1
NA 1

Registries

Studies by Country

Country Study_Count
Morocco 1
United States 1

Sites per Study

Site_count Study_Count
1 1
4 1

Enrollment Metrics

Measure Registries
Min 30.0
1st Qu 397.5
Median 765.0
Mean 765.0
3rd Qu 1132.5
Max 1500.0

Registry Model

observational_model Study_Count
Cohort 2

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
3 Years 1
48 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04137289 A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT04137289 Recruiting Boehringer Ingelheim 2023-04-04
NCT03337087 Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer https://ClinicalTrials.gov/show/NCT03337087 Recruiting Academic and Community Cancer Research United 2020-11-07
NCT03329690 DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] https://ClinicalTrials.gov/show/NCT03329690 Active, not recruiting Daiichi Sankyo, Inc. 2020-09-30
NCT03321396 Hydrogel Injection to Assist Endoscopic Submucosal Dissection https://ClinicalTrials.gov/show/NCT03321396 Completed National Cheng-Kung University Hospital 2018-08-20
NCT03309917 The Effect of Blood Pressure on Cerebral Blood Flow During Propofol Anesthesia https://ClinicalTrials.gov/show/NCT03309917 Completed Rigshospitalet, Denmark 2018-04-19
NCT03306693 Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers https://ClinicalTrials.gov/show/NCT03306693 Recruiting University Hospital, Lille 2019-10-31
NCT03271255 Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) https://ClinicalTrials.gov/show/NCT03271255 Recruiting Shenzhen People’s Hospital 2022-09-30
NCT03267524 Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers https://ClinicalTrials.gov/show/NCT03267524 Active, not recruiting City of Hope Medical Center 2020-11-30
NCT03221335 EUS-guided RFA for Solid Abdominal Neoplasms https://ClinicalTrials.gov/show/NCT03221335 Recruiting Chinese University of Hong Kong 2021-04-30
NCT03172403 Skeletal Muscle Expression of Myostatin and Cancer of Digestive System Associated Cachexia https://ClinicalTrials.gov/show/NCT03172403 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2020-08-01
NCT03117348 Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients https://ClinicalTrials.gov/show/NCT03117348 Completed Jinling Hospital, China 2018-12-24
NCT03115957 Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients https://ClinicalTrials.gov/show/NCT03115957 Completed Jinling Hospital, China 2018-12-30
NCT03072472 BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities https://ClinicalTrials.gov/show/NCT03072472 Completed South Tyneside and Sunderland NHS Foundation Trust 2018-02-13
NCT02897778 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02897778 Completed Syndax Pharmaceuticals 2017-03-31
NCT02859064 Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres https://ClinicalTrials.gov/show/NCT02859064 Active, not recruiting SCRI Development Innovations, LLC 2020-04-30
NCT02795988 A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer https://ClinicalTrials.gov/show/NCT02795988 Recruiting Imugene Limited 2020-12-31
NCT02785783 Endoringsâ„¢ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection https://ClinicalTrials.gov/show/NCT02785783 Completed Portsmouth Hospitals NHS Trust 2018-08-07
NCT02784652 Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT02784652 Completed Severance Hospital 2017-02-28
NCT02744651 EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract https://ClinicalTrials.gov/show/NCT02744651 Recruiting Region Skane 2020-09-30
NCT02713269 Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord https://ClinicalTrials.gov/show/NCT02713269 Recruiting M.D. Anderson Cancer Center 2022-07-01
NCT02575898 Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study https://ClinicalTrials.gov/show/NCT02575898 Completed Dartmouth-Hitchcock Medical Center 2018-07-12
NCT02631590 Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02631590 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2019-11-23
NCT02507414 Mesenteric Traction Syndrome During Upper Gastrointestinal Surgery https://ClinicalTrials.gov/show/NCT02507414 Completed Rigshospitalet, Denmark 2016-09-30
NCT02485561 Evaluating Strategies to Present Colon Cancer Screening Information https://ClinicalTrials.gov/show/NCT02485561 Completed Washington University School of Medicine 2017-01-31
NCT02450656 Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02450656 Recruiting The Netherlands Cancer Institute 2019-05-31
NCT02444572 Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® https://ClinicalTrials.gov/show/NCT02444572 Recruiting Les Laboratoires des Médicaments Stériles 2020-12-31
NCT02356471 Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery https://ClinicalTrials.gov/show/NCT02356471 Completed Wake Forest University Health Sciences 2016-10-31
NCT02333188 Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT02333188 Completed University of Chicago 2017-12-31
NCT02319018 Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT02319018 Completed National Cancer Institute (NCI) 2018-09-29
NCT02312167 Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) https://ClinicalTrials.gov/show/NCT02312167 Completed Institut Mutualiste Montsouris 2015-10-31
NCT02221700 Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies https://ClinicalTrials.gov/show/NCT02221700 Active, not recruiting M.D. Anderson Cancer Center 2020-04-30
NCT02192333 Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors https://ClinicalTrials.gov/show/NCT02192333 Active, not recruiting Fred Hutchinson Cancer Research Center 2017-10-07
NCT01291407 A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer https://ClinicalTrials.gov/show/NCT01291407 Completed Chinese Academy of Medical Sciences 2013-08-31
NCT02056015 A Phase I Study of MLN6907 in Patients With Metastatic Colorectal https://ClinicalTrials.gov/show/NCT02056015 Completed Takeda 2015-09-30
NCT01996306 A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC https://ClinicalTrials.gov/show/NCT01996306 Completed Epidemiological and Clinical Research Information Network 2017-11-20
NCT01982994 Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients https://ClinicalTrials.gov/show/NCT01982994 Completed Milton S. Hershey Medical Center 2015-07-31
NCT01964430 Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the “Apact” Study) https://ClinicalTrials.gov/show/NCT01964430 Active, not recruiting Celgene 2018-12-31
NCT01946854 Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei https://ClinicalTrials.gov/show/NCT01946854 Recruiting M.D. Anderson Cancer Center 2021-07-31
NCT01916447 A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors. https://ClinicalTrials.gov/show/NCT01916447 Completed Taiho Oncology, Inc. 2017-09-30
NCT01832116 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients https://ClinicalTrials.gov/show/NCT01832116 Completed University Medical Center Groningen 2014-05-31
NCT01790035 Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT01790035 Active, not recruiting Washington University School of Medicine 2017-01-12
NCT01693445 S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT01693445 Completed Hallym University Medical Center 2014-02-28
NCT01640665 Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT01640665 Completed Yale University 2014-08-31
NCT01639911 Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT01639911 Completed University of Illinois at Chicago 2016-07-28
NCT01625351 A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas https://ClinicalTrials.gov/show/NCT01625351 Active, not recruiting St. Jude Children’s Research Hospital 2020-09-18
NCT01567488 Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET https://ClinicalTrials.gov/show/NCT01567488 Completed Grupo Espanol de Tumores Neuroendocrinos 2014-09-01
NCT01552291 The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies https://ClinicalTrials.gov/show/NCT01552291 Completed University Hospital Inselspital, Berne 2018-02-10
NCT01476592 A Biological Study of Resveratrol’s Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT01476592 Completed University of Wisconsin, Madison 2013-10-31
NCT01434069 Phase I Trial of Combination of FOLFIRI and SOM 230 https://ClinicalTrials.gov/show/NCT01434069 Completed H. Lee Moffitt Cancer Center and Research Institute 2015-12-31
NCT04426669 A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering https://ClinicalTrials.gov/show/NCT04426669 Recruiting Intima Bioscience, Inc. 2022-10-31
NCT04393584 FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma https://ClinicalTrials.gov/show/NCT04393584 Recruiting Blokhin’s Russian Cancer Research Center 2024-01-01
NCT04207463 A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT04207463 Recruiting Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2020-12-31
NCT04197310 Cabozantinib and Nivolumab for Carcinoid Tumors https://ClinicalTrials.gov/show/NCT04197310 Recruiting Dana-Farber Cancer Institute 2021-12-26
NCT04171141 Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. https://ClinicalTrials.gov/show/NCT04171141 Recruiting Pfizer 2023-06-14
NCT04145297 Ulixertinib (BVD-523) and Hydroxychloroquine in Patients w Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas https://ClinicalTrials.gov/show/NCT04145297 Recruiting University of Utah 2023-01-30
NCT04084249 Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer - Intervention Trial 2 https://ClinicalTrials.gov/show/NCT04084249 Recruiting University of Aarhus 2022-12-01
NCT04080843 Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients https://ClinicalTrials.gov/show/NCT04080843 Recruiting Zhejiang University 2020-08-31
NCT04010227 Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers https://ClinicalTrials.gov/show/NCT04010227 Recruiting Indiana University 2021-05-31
NCT03978078 A Clinicobiological Database in Metastatic Digestive Cancers https://ClinicalTrials.gov/show/NCT03978078 Recruiting Institut du Cancer de Montpellier - Val d’Aurelle 2021-04-30
NCT03800693 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT03800693 Recruiting Emory University 2021-03-31
NCT03724071 Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. https://ClinicalTrials.gov/show/NCT03724071 Recruiting Transgene 2020-12-31
NCT03717298 Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma https://ClinicalTrials.gov/show/NCT03717298 Recruiting Catalysis SL 2020-10-30
NCT03602677 Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage https://ClinicalTrials.gov/show/NCT03602677 Recruiting Oulu University Hospital 2020-09-01
NCT03597581 A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT03597581 Recruiting Rgenix, Inc. 2020-07-31
NCT03559543 Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma https://ClinicalTrials.gov/show/NCT03559543 Recruiting Catalysis SL 2020-11-30
NCT03549494 Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction https://ClinicalTrials.gov/show/NCT03549494 Recruiting Catalysis SL 2020-11-01
NCT03535727 A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer https://ClinicalTrials.gov/show/NCT03535727 Recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2021-06-30
NCT03507998 Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT03507998 Recruiting Curegenix Inc. 2020-04-01
NCT03449030 A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) https://ClinicalTrials.gov/show/NCT03449030 Completed Takeda 2020-02-27
NCT03411915 A Study of XmAb®18087 in Subjects With NET and GIST https://ClinicalTrials.gov/show/NCT03411915 Recruiting Xencor, Inc. 2021-03-31
NCT01129310 First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. https://ClinicalTrials.gov/show/NCT01129310 Completed AHS Cancer Control Alberta 2018-05-18
NCT01037049 Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks https://ClinicalTrials.gov/show/NCT01037049 Active, not recruiting Royal Marsden NHS Foundation Trust 2014-12-08
NCT00990535 High Dose Somatostatin Analogues in Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT00990535 Completed Federico II University 2007-12-31
NCT01927965 Study of Minnelideâ„¢ in Patients With Advanced GI Tumors https://ClinicalTrials.gov/show/NCT01927965 Completed Minneamrita Therapeutics LLC 2016-10-31
NCT03037385 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03037385 Recruiting Blueprint Medicines Corporation 2021-12-31
NCT02837679 Oncogeriatric Intervention and Follow-up at Home https://ClinicalTrials.gov/show/NCT02837679 Active, not recruiting University of Aarhus 2019-09-30
NCT02148159 Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer https://ClinicalTrials.gov/show/NCT02148159 Completed University of Florida 2016-05-31
NCT04447443 Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT04447443 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2021-06-30
NCT00793871 Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor https://ClinicalTrials.gov/show/NCT00793871 Completed Pfizer 2014-04-30
NCT00725712 Study of GSK1363089 in Metastatic Gastric Cancer https://ClinicalTrials.gov/show/NCT00725712 Completed GlaxoSmithKline 2009-11-01
NCT00680901 LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib https://ClinicalTrials.gov/show/NCT00680901 Active, not recruiting Novartis 2012-09-24
NCT00570635 A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib https://ClinicalTrials.gov/show/NCT00570635 Completed Exelixis 2009-05-31
NCT00526669 Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib https://ClinicalTrials.gov/show/NCT00526669 Completed GlaxoSmithKline 2011-04-30
NCT00486954 Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer https://ClinicalTrials.gov/show/NCT00486954 Completed GlaxoSmithKline 2012-01-31
NCT00465725 A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors https://ClinicalTrials.gov/show/NCT00465725 Completed Poniard Pharmaceuticals 2009-07-31
NCT00436657 Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer https://ClinicalTrials.gov/show/NCT00436657 Completed M.D. Anderson Cancer Center 2011-04-30
NCT00422409 Endoscopic Stenting of Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00422409 Completed Oslo University Hospital 2009-04-30
NCT00392366 Laser Interstitial Thermal Therapy Under “Real Time” MRI Guidance for “Minimal Invasive” Treatment of Liver Metastasis https://ClinicalTrials.gov/show/NCT00392366 Completed BioTex, Inc. NA
NCT00390182 Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) https://ClinicalTrials.gov/show/NCT00390182 Completed University of Maryland, Baltimore 2011-05-31
NCT00289445 Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) https://ClinicalTrials.gov/show/NCT00289445 Completed University Hospital Tuebingen 2006-03-31
NCT00247338 The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients https://ClinicalTrials.gov/show/NCT00247338 Completed Sino-Swed Pharmaceutical Corporation 2006-04-30
NCT00220168 Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours https://ClinicalTrials.gov/show/NCT00220168 Completed Royal Marsden NHS Foundation Trust NA
NCT00220064 A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours https://ClinicalTrials.gov/show/NCT00220064 Completed Royal Marsden NHS Foundation Trust NA
NCT00196885 Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training https://ClinicalTrials.gov/show/NCT00196885 Completed German Cancer Research Center NA
NCT00190801 Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma https://ClinicalTrials.gov/show/NCT00190801 Completed Eli Lilly and Company NA
NCT00120939 Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer https://ClinicalTrials.gov/show/NCT00120939 Completed Pharmacyclics LLC. NA
NCT00826410 Prospective Study on the Value of Subcutaneous Drains in Gastrointestinal Surgery https://ClinicalTrials.gov/show/NCT00826410 Completed University Hospital Freiburg 2004-12-31
NCT00052962 Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis https://ClinicalTrials.gov/show/NCT00052962 Completed National Institutes of Health Clinical Center (CC) 2008-09-30
NCT00001431 A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas https://ClinicalTrials.gov/show/NCT00001431 Completed National Institutes of Health Clinical Center (CC) NA
NCT00041808 Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver https://ClinicalTrials.gov/show/NCT00041808 Completed FeRx NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03130621 Screening of Hereditary Upper Gastrointestinal Cancer in China https://ClinicalTrials.gov/show/NCT03130621 Recruiting Peking University 2022-03-31
NCT03050333 Efficacy and Safety of Endoscopic Resection https://ClinicalTrials.gov/show/NCT03050333 Recruiting Fundacion Miguel Servet 2022-12-31
NCT02951273 Cerebral Blood Flow During Propofol Anaesthesia https://ClinicalTrials.gov/show/NCT02951273 Completed Rigshospitalet, Denmark 2017-07-06
NCT02781532 Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestive Cancer https://ClinicalTrials.gov/show/NCT02781532 Completed Centre Hospitalier Universitaire de Nice 2015-01-31
NCT02486094 Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging https://ClinicalTrials.gov/show/NCT02486094 Completed Royal Marsden NHS Foundation Trust 2016-09-01
NCT02226224 Endoscopic Ultrasound in Detailed T-staging of Upper GI Malignancies in Vitro https://ClinicalTrials.gov/show/NCT02226224 Recruiting Beijing Cancer Hospital 2020-10-31
NCT02196935 Los Angeles Prospective GI Biliary and EUS Series https://ClinicalTrials.gov/show/NCT02196935 Recruiting University of Southern California 2020-12-31
NCT02005965 Low Rectal Cancer Study (MERCURY II) https://ClinicalTrials.gov/show/NCT02005965 Active, not recruiting Royal Marsden NHS Foundation Trust 2016-03-11
NCT01995942 Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial https://ClinicalTrials.gov/show/NCT01995942 Active, not recruiting Royal Marsden NHS Foundation Trust 2017-02-02
NCT01816607 Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness https://ClinicalTrials.gov/show/NCT01816607 Completed University Hospital, Akershus 2017-12-31
NCT01750619 Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions https://ClinicalTrials.gov/show/NCT01750619 Recruiting California Pacific Medical Center Research Institute 2021-12-31
NCT01415609 Endoscopic Submucosal Dissection Registry https://ClinicalTrials.gov/show/NCT01415609 Completed Mayo Clinic 2012-03-31
NCT04133324 C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer https://ClinicalTrials.gov/show/NCT04133324 Recruiting Moroccan Society of Surgery 2023-12-31
NCT03763526 Association Between Perioperative Nutritional Status and Surgical Outcome in Digestive System Cancer Patients https://ClinicalTrials.gov/show/NCT03763526 Recruiting Mahidol University 2020-08-01
NCT03621852 Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®) https://ClinicalTrials.gov/show/NCT03621852 Recruiting Philipps University Marburg Medical Center 2019-07-01
NCT03568019 PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT03568019 Active, not recruiting University of Texas Southwestern Medical Center 2023-05-26
NCT03563352 Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer https://ClinicalTrials.gov/show/NCT03563352 Recruiting University of Southern California 2020-08-30
NCT02454647 Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients https://ClinicalTrials.gov/show/NCT02454647 Completed Clinica Universidad de Navarra, Universidad de Navarra 2015-03-31
NCT01621295 Assessing the Patient Experience in Cancer Care https://ClinicalTrials.gov/show/NCT01621295 Completed Mayo Clinic 2015-09-30
NCT00584363 Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection https://ClinicalTrials.gov/show/NCT00584363 Completed University of Alabama at Birmingham 2017-09-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04361227 Utility of OverStitch Sx After ESD https://ClinicalTrials.gov/show/NCT04361227 Recruiting Baylor College of Medicine 2021-12-31
NCT03681600 Observatory of the Quality of Surgical Procedures for Digestive Cancers https://ClinicalTrials.gov/show/NCT03681600 Recruiting Moroccan Society of Surgery 2020-12-31